|
Market Closed -
Euronext Paris
11:55:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 0.2960 EUR | +2.78% |
|
+5.34% | -0.67% |
| 10-30 | Nicox sharply narrows first-half 2026 loss and secures cash runway through 2028 |  |
| 10-30 | Nicox S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NICOX SA | Specialty & Advanced Pharmaceuticals | +2.78% | +5.34% | -0.67% | -7.79% | -90.84% | 28.3M |  | |  |
- Stock Market
- Stocks
- ALCOX Stock
- Charts Nicox SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
